These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. In vivo action of glibenclamide in obese subjects with mild type 2 (non-insulin dependent) diabetes. Hother-Nielsen O; Schmitz O; Andersen PH; Pedersen O; Beck-Nielsen H Diabetes Res; 1988 Jun; 8(2):63-70. PubMed ID: 3147830 [TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major. Suvarna J; Ingle H; Deshmukh CT Indian Pediatr; 2006 May; 43(5):393-400. PubMed ID: 16735760 [TBL] [Abstract][Full Text] [Related]
8. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. Nolan JJ; Ludvik B; Beerdsen P; Joyce M; Olefsky J N Engl J Med; 1994 Nov; 331(18):1188-93. PubMed ID: 7935656 [TBL] [Abstract][Full Text] [Related]
9. Abnormal glucose tolerance in beta-thalassemia: assessment of risk factors. Hafez M; Youssry I; El-Hamed FA; Ibrahim A Hemoglobin; 2009; 33(2):101-8. PubMed ID: 19373585 [TBL] [Abstract][Full Text] [Related]
10. Insulin and IGF1 receptor function among type II diabetic responders and nonresponders to glyburide. Grunberger G J Lab Clin Med; 1993 Apr; 121(4):555-61. PubMed ID: 8454937 [TBL] [Abstract][Full Text] [Related]
11. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia. Ramos GA; Jacobson GF; Kirby RS; Ching JY; Field DR J Perinatol; 2007 May; 27(5):262-7. PubMed ID: 17363911 [TBL] [Abstract][Full Text] [Related]
12. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Anderwald C; Anderwald-Stadler M; Promintzer M; Prager G; Mandl M; Nowotny P; Bischof MG; Wolzt M; Ludvik B; Kästenbauer T; Pacini G; Luger A; Krebs M Diabetes Care; 2007 Sep; 30(9):2374-80. PubMed ID: 17595351 [TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093 [TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity. Petrides AS; Stanley T; Matthews DE; Vogt C; Bush AJ; Lambeth H Hepatology; 1998 Jul; 28(1):141-9. PubMed ID: 9657106 [TBL] [Abstract][Full Text] [Related]
15. Effect of fetal hyperinsulinism on oral glucose tolerance test results in patients with gestational diabetes mellitus. Weiss PA; Scholz HS; Haas J; Tamussino KF Am J Obstet Gynecol; 2001 Feb; 184(3):470-5. PubMed ID: 11228505 [TBL] [Abstract][Full Text] [Related]
16. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Langer O; Yogev Y; Xenakis EM; Rosenn B Am J Obstet Gynecol; 2005 Jan; 192(1):134-9. PubMed ID: 15672015 [TBL] [Abstract][Full Text] [Related]
17. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals. DeFronzo RA; Simonson DC Diabetes Care; 1984; 7 Suppl 1():72-80. PubMed ID: 6428844 [TBL] [Abstract][Full Text] [Related]
18. Insulin and glucagon responses to provocation with glucose and arginine in prepubertal children with thalassemia major before and after long-term blood transfusion. Soliman AT; el Banna N; alSalmi I; Asfour M J Trop Pediatr; 1996 Oct; 42(5):291-6. PubMed ID: 8936961 [TBL] [Abstract][Full Text] [Related]